Janssen Pharmaceuticals
Search results
Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here. In the list below, the entry for each authorized drug and vaccine includes the: authorization holder.
- Applications Received
The list below includes all applications received by Health...
- Overview
The ISAD IO facilitated timely access for Canadians to drugs...
- Janssen
All COVID-19 vaccines authorized in Canada are proven safe,...
- Applications Received
- On This Page
- Who The Vaccine Was Approved For
- Effectiveness
- Dosage
- Vaccine Ingredients
- Possible Side Effects
- Vaccine Review, Approval and Monitoring
- Related Links
The vaccine was approved for people who are 18 years of age and older. Its safety and effectiveness in people younger than 18 years of age have not yet been established.
Clinical trials showed that beginning 2 weeks after the single dose, the Janssen Jcovden®COVID-19 vaccine was 66% effective in protecting trial participants against COVID-19.
This vaccine requires a single dose. A booster dose of the Janssen Jcovden®COVID-19 vaccine may be given to individuals 18 years of age and older at least 2 months after completing their primary vaccine series. A booster dose of the Janssen Jcovden®COVID-19 vaccine may also be given to individuals 18 years of age and older 3-6 months after completi...
Medicinal ingredient
1. adenovirus vector vaccine
Other ingredients
1. 2-hydroxypropyl-β-cyclodextrin (HBCD) 2. citric acid monohydrate 3. ethanol 4. hydrochloric acid 5. polysorbate 80 6. sodium chloride 7. sodium hydroxide 8. trisodium citrate dihydrate 9. water for injection
After getting vaccinated, it's common to have temporary side effects. These can last a few hours to a few daysafter vaccination. This is the body's natural response, as it's working hard to build protection against the disease.
Health Canada's independent drug review and approval process is recognized around the world for its high standards and rigor. Our decisions are based only on scientific and medical evidence showing that vaccines are safe and effective. The benefits must also outweigh any risks. The Janssen COVID-19 vaccine was authorized for use in Canada under the...
Jun 6, 2022 · The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for the use of the Janssen Ad26.COV2.S COVID-19 vaccine against COVID-19. Here is what you need to know. This article provides a summary of the interim recommendations; the interim recommendations and the background document are also available.
Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK.
Mar 12, 2021 · The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday. “Every new, safe and effective tool against ...
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson.
The Janssen vaccine is the first single-dose COVID-19 vaccine to be authorized in Canada, and can be stored and transported at refrigerated temperatures (from 2˚ to 8˚C) for at least three months, facilitating distribution across the country.
Ad
related to: janssen vaccines listView Relevant Reviews, Information and Discover Names Of Vaccines Information. Read and Explore Names Of Vaccines. Find Top Information and More.
